Lack of support for bexarotene as a treatment for Alzheimer's disease.

Autoria(s): O'Hare, Eugene; Jeggo, Ross; Kim, Eun-Mee; Barbour, Bridgeen; Walczak, Jean-Sebastian; Palmer, Philip; Lyons, Taylor; Page, Deaglan; Hanna, Donncha; Meara, Jolyon R.; Spanswick, David; Guo, Jian-Ping; McGeer, Edith G.; McGeer, Patrick L.; Hobson, Peter
Data(s)

01/01/2016
Identificador

http://pure.qub.ac.uk/portal/en/publications/lack-of-support-for-bexarotene-as-a-treatment-for-alzheimers-disease(c7e7b287-d74b-4a9e-ad8a-7cfff6ffeea7).html

http://pure.qub.ac.uk/ws/files/18490016/NEUROPHARM_D_15_00161.pdf
Idioma(s)

eng
Direitos

info:eu-repo/semantics/openAccess
Fonte

O'Hare , E , Jeggo , R , Kim , E-M , Barbour , B , Walczak , J-S , Palmer , P , Lyons , T , Page , D , Hanna , D , Meara , J R , Spanswick , D , Guo , J-P , McGeer , E G , McGeer , P L & Hobson , P 2016 , ' Lack of support for bexarotene as a treatment for Alzheimer's disease. ' Neuropharmacology , vol 100 , pp. 124-130 .
Tipo

article
Formato

application/pdf
Acesso ao item digital